All In Biotech

Drug Trial Radar · NCT07284459

Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Oral PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 324 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

324

Planned (sponsor's estimate)

Start

Jan 8, 2026

Primary completion

May 2028

Study completion Jun 2028

Sponsor

Lead sponsor
Contineum TherapeuticsIndustry
Sponsor type
Industry
First posted
Dec 16, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Ph 2, randomized, double-blind, placebo-controlled global multicenter study to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of PIPE-791 in participants with a diagnosis of Idiopathic Pulmonary Fibrosis (IPF) with or without background treatment.

Conditions

  • Idiopathic Pulmonary Fibrosis

Interventions

  • PIPE-791 Dose ADrug

    Participants will receive a daily oral dose of PIPE-791 in tablet form

  • PIPE-791 Dose BDrug

    Participants will receive a daily oral dose of PIPE-791 in tablet form

  • PlaceboDrug

    Participants will receive a daily oral dose of matching Placebo in tablet form

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Absolute change in forced vital capacity (FVC) (mL)Time frame: From baseline to Week 26

Locations

113 sites in 19 countries. Site status is shown where the registry gives one.

  • STAT Research S.A.

    Buenos Aires, Argentina · Recruiting

  • Consultorios Médicos Organización del Buen Ayre SRL

    Buenos Aires, Argentina · Recruiting

  • Centro Médico Dra de Salvo - Fundacion Respirar - PPDS

    Buenos Aires, Argentina · Recruiting

  • Instituto de Medicina Respiratoria - IMER

    Córdoba, Argentina · Recruiting

  • IbaMedica

    Santa Fe, Argentina · Recruiting

  • Instituto Ave Pulmo

    Mar del Plata, Buenos Aires, Argentina · Recruiting

  • Centro Respiratorio Quilmes

    Quilmes, Buenos Aires, Argentina · Recruiting

  • CINME S.A. - Centro de Investigaciones Metabólicas - Viamonte 2213/2215

    Buenos Aires, Buenos Aires F.D., Argentina · Recruiting

  • Instituto de Especialidades de la Salud Rosario - Clínica del Tórax

    Rosario, Santa Fe Province, Argentina · Recruiting

  • Instituto Médico de la Fundación Estudios Clínicos

    Rosario, Santa Fe Province, Argentina · Recruiting

  • Centro de Diagnóstico Y Rehabilitación - Santa Fe - San Luis

    San Luis, Santa Fe Province, Argentina · Recruiting

  • Centro de Investigaciones Médicas Tucumán - PPDS

    San Miguel de Tucumán, Tucumán Province, Argentina · Recruiting

  • CIMER-Centro Integral de Medicina Respiratoria

    San Miguel de Tucumán, Tucumán Province, Argentina · Recruiting

  • IPR-Investigaciones en Patologías Respiratorias

    San Miguel de Tucumán, Tucumán Province, Argentina · Recruiting

  • Centro Modelo de Cardiología-Laprida 554

    San Miguel de Tucumán, Tucumán Province, Argentina · Recruiting

  • Royal Prince Alfred Hospital

    Camperdown, New South Wales, Australia · Recruiting

  • Westmead Hospital

    Westmead, New South Wales, Australia · Recruiting

  • Lung Research Qld

    Chermside, Queensland, Australia · Recruiting

  • The Prince Charles Hospital

    Chermside, Queensland, Australia · Recruiting

  • Greenslopes Private Hospital

    Greenslopes, Queensland, Australia · Recruiting

  • Austin Health

    Heidelberg, Victoria, Australia · Recruiting

  • The Alfred Hospital

    Melbourne, Victoria, Australia · Recruiting

  • Institute for Respiratory Health

    Midland, Western Australia, Australia · Recruiting

  • TrialsWest Pty Ltd

    Spearwood, Western Australia, Australia · Recruiting

  • Cliniques Universitaires Saint-Luc - PPDS

    Brussels, Belgium · Recruiting

  • CHU UCL Namur - Site Godinne

    Yvoir, Belgium · Recruiting

  • Vancouver General Hospital

    Vancouver, British Columbia, Canada · Recruiting

  • Dynamic Drug Advancement Ltd.

    Ajax, Ontario, Canada · Recruiting

  • Toronto General Hospital

    Toronto, Ontario, Canada · Recruiting

  • Dr. Anil Dhar Medicine Professional Corporation

    Windsor, Ontario, Canada · Recruiting

  • Centre Hospitalier de l'Universite de Montreal

    Montreal, Quebec, Canada · Recruiting

  • Institut Universitaire de Cardiologie et de Pneumologie de Quebec - Université Laval

    Québec, Quebec, Canada · Recruiting

  • Centre d'investigation Clinique Mauricie

    Trois-Rivières, Quebec City, Canada · Recruiting

  • Centro de Investigacion Curicó

    Curicó, Maule Region, Chile · Recruiting

  • CEC SpA

    Ñuñoa, Santiago Metropolitan, Chile · Recruiting

  • Biocinetic Servicios Medicos Ltda

    Santiago, Santiago Metropolitan, Chile · Recruiting

  • Centro de Investigacion de Enfermedades Respiratorias e Inmunologicas

    Viña del Mar, Valparaiso, Chile · Recruiting

  • Centro de Investigaciones Clinicas Vina del Mar

    Viña del Mar, Valparaiso, Chile · Recruiting

  • Odense Universitetshospital

    Odense C, Region Syddanmark, Denmark · Recruiting

  • Hospices Civils de Lyon - Groupement Hospitalier Est

    Bron, France · Recruiting

Showing 40 of 113 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.